Cost-minimization and budget impact analysis of bypassing agents in hemophilia A with inhibitors: a Brazilian study

OBJECTIVE: The aim of the study was to compare the treatment with plasma-derived activated prothrombin complex concentrate (APCC) and recombinant activated FVII (rFVIIa) in patients with Hemophilia A with inhibitors, analyzing the costs and budget impact of prophylactic and on-demand treatment in t...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Christiane Maria da Silva Pinto, André Luis Souza Silveira, Fábio Carvalho, Janaina da Silva, Tatiane Bomfim Ribeiro, Gabriela Vilela de Brito
Формат: Artigo
Язык:Inglês
Опубликовано: Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia 2025-08-01
Серии:Jornal de Assistência Farmacêutica e Farmacoeconomia
Предметы:
Blood Coagulation Factors
Hemophilia A
Blood Coagulation Factor Inhibitors
Hematologic Agents
Factor VIIa
Health Care Economics and Organizations
Online-ссылка:https://ojs.jaff.org.br/ojs/index.php/jaff/article/view/1055
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы